ImmunoPrecise Antibodies Ltd. (IPA) Social Stream
IMMUNOPRECISE ANTIBODIES LTD (IPA) Price Targets From Analysts
Use the tables below to see what analysts covering IMMUNOPRECISE ANTIBODIES LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-08 | 1 | $12 | $12 | $12 | $1.47 | 716.33% |
| 2022-04-14 | 1 | $12.001 | $12.001 | $12.001 | $1.47 | 716.39% |
| 2023-03-17 | 2 | $12.001 | $9 | $10.5 | $1.47 | 614.29% |
| 2023-12-15 | 2 | $7 | $6.75 | $6.875 | $1.47 | 367.69% |
The Trend in the Analyst Price Target
IPA's average price target has moved down $8.03 over the prior 36 months.
Over the past 39 weeks, IPA's average upside potential has been 283.8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 1 | 12.001 | 9.00 | 10.500 | 3.31 | 217.22% |
| 2023-03-21 | 2 | 9.000 | 7.00 | 8.000 | 3.08 | 159.74% |
| 2023-07-12 | 2 | 9.000 | 7.00 | 8.000 | 2.99 | 167.56% |
| 2023-09-18 | 2 | 9.000 | 7.00 | 8.000 | 1.79 | 346.93% |
| 2023-12-15 | 2 | 7.000 | 6.75 | 6.875 | 1.38 | 398.19% |
IPA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
IPA's average broker recommendation rating improved by 0 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- IMMUNOPRECISE ANTIBODIES LTD's number of analysts covering the stock is higher than 8.49% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IMMUNOPRECISE ANTIBODIES LTD's upside potential (average analyst target price relative to current price) is greater than 568.05% of them.
- IMMUNOPRECISE ANTIBODIES LTD's variance in analysts' estimates is lower than 54.05% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, IMMUNOPRECISE ANTIBODIES LTD's average analyst price target is higher than 104% of them.
In the Pharmaceutical Products industry, GANX, UPC, and HCWB are the three stocks most similar to IMMUNOPRECISE ANTIBODIES LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding IPA using the data that counts. Try POWR Ratings for free.